BioCentury
ARTICLE | Financial News

Affymetrix's preliminary 2Q revenue misses Street

July 7, 2011 12:18 AM UTC

Affymetrix Inc. (NASDAQ:AFFX) said late Wednesday it expects 2Q11 revenue to be $64-$65 million, below the Street's estimate of $74.1 million. The microarray company attributed the lower revenue to de...